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Objective: Multimorbidity (MM) is more prevalent among people of lower socioeconomic status 
(SES), and both MM and SES are associated with higher mortality rates. However, little is known 
about the relationship between SES, MM, and mortality. This study investigates the association 
between educational level and mortality, and to what extent MM modifies this association.
Methods: We followed 239,547 individuals invited to participate in the Danish National 
Health Survey 2010 (mean follow-up time: 3.8 years). MM was assessed by using information 
on drug prescriptions and diagnoses for 39 long-term conditions. Data on educational level 
were provided by Statistics Denmark. Date of death was obtained from the Civil Registration 
System. Information on lifestyle factors and quality of life was collected from the survey. The 
main outcomes were overall and premature mortality (death before the age of 75).
Results: Of a total of 12,480 deaths, 6,607 (9.5%) were of people with low educational level 
(LEL) and 1,272 (2.3%) were of people with high educational level (HEL). The mortality rate 
was higher among people with LEL compared with HEL in groups of people with 0–1 disease 
(hazard ratio: 2.26, 95% confidence interval: 2.00–2.55) and ≥4 diseases (hazard ratio: 1.14, 95% 
confidence interval: 1.04–1.24), respectively (adjusted model). The absolute number of deaths 
was six times higher among people with LEL than those with HEL in those with ≥4 diseases. 
The 1-year cumulative mortality proportions for overall death in those with ≥4 diseases was 
5.59% for people with HEL versus 7.27% for people with LEL, and 1-year cumulative mortality 
proportions for premature death was 2.93% for people with HEL versus 4.04% for people with 
LEL. Adjusting for potential mediating factors such as lifestyle and quality of life eliminated 
the statistical association between educational level and mortality in people with MM.
Conclusion: Our study suggests that LEL is associated with higher overall and premature 
mortality and that the association is affected by MM, lifestyle factors, and quality of life.
Keywords: multimorbidity, socioeconomic status, social epidemiology, inequality in health, 
mortality, population-based cohort study
Introduction
The pattern of health challenges has changed over the recent decades. Chronic diseases 
now account for majority of deaths in developed countries.1 The rising prevalence of 
multiple chronic diseases in an increasingly aging population2,3 poses considerable 
challenges in the highly specialized health care systems, which primarily focus on 
treating single diseases.4–6 MM is associated with several adverse health outcomes, 
including high health care utilization,7 unplanned hospital admission,8 lower quality 
of life,9–13 mental health disorders,14 lower functional level,15–17 higher prevalence of 
pain,18 and higher mortality rates.19–21
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Several cross-sectional studies have reported that the 
prevalence of MM is socially patterned. This has been 
shown by using various deprivation indices as proxies for 
socioeconomic status (SES).22–24 Barnett et al found that MM 
occurs 10–15 years earlier in people living in deprived areas 
of Scotland compared with affluent areas. Socioeconomic 
deprivation is particularly associated with MM involving 
mental health disorders.14 Other studies have investigated 
educational level as a risk factor for developing long-term 
disease, and these have confirmed that MM is more common 
among people with low SES.25–28
It is well established in many European countries that 
people with low educational level (LEL) (as a measure for 
SES) have higher mortality than those with high educational 
level (HEL). This difference illustrates the considerable 
inequalities in health.29–32 As knowledge on the association 
between educational level, MM, and mortality is limited, 
prospective studies are warranted on the impact of SES on 
the long-term survival in people with MM.33
The objective of this study was to examine the impact of 
educational level on all-cause mortality when taking MM 
status into account. Poor lifestyle choices are known to be 
associated with MM,34 low SES,35 and high mortality.36 This 
underlines the importance of including relevant lifestyle 
factors when answering the research question. We used a 
large population-based cohort comprising a representative 
sample of the Danish population to compare information 
on socioeconomic factors, morbidity burden, and specific 
lifestyle factors. A 4-year follow-up study was conducted, and 
additionally, lifestyle was further investigated for a subgroup. 
We hypothesized that low SES, chronic disease burden, and 
poor lifestyle choices would interact and contribute to an 
impaired prognosis in people with MM.
Methods
Study design
This nationwide population-based cohort study with pro-
spectively recorded data was conducted using information 
on people who were invited to participate in the Danish 
National Health Survey 2010.37 The survey population 
consisted of a random nationally representative sample of 
all Danish citizens from each of the five Danish regions 
and an additional national sample invited by the National 
Institute of Public Health. Information collected through a 
paper- and web-based survey questionnaire was linked to 
nationwide health registries at the personal level by using 
the unique 10-digit civil personal registration (CPR) number 
assigned to all Danish residents upon birth or immigration.38 
Register data were collected prospectively. All participants 
entered the study on May 1, 2010 (baseline), at which time 
all questionnaires were collected. They were followed until 
death or emigration, or at the endpoint of the study (March 
2014, 29), whichever came first.
Study population
We included all people who were invited to participate in 
the survey. Inclusion criteria were 25–89 years of age at 
baseline and residing in Denmark since January 1, 1995, to 
ensure the most complete register information. Participants 
with missing information on educational level (n=2,956) 
were excluded from the analyses. The study population 
(n=239,547) was subsequently divided into two sub-cohorts: 
survey respondents and nonrespondents, (Figure 1) leaving 
us with three cohorts; two sub-cohorts contained within the 
study population cohort.
Exposure
MM status
The study population was categorized with MM if they had 
two or more of the selected 39 long-term conditions, which 
have previously been defined and used in Danish cohorts39 
based on recommendations in systematic reviews.40,41 The 
conditions were identified by combining data from the Danish 
National Patient Register,42 the Danish Cancer Register,43 the 
Danish Diabetes Register,44 the Danish Psychiatric Central 
Register,45 and the Danish National Prescription Registry46 
from 1995 up until the baseline of study. Conditions were 
considered to be either physical or mental.39 We divided the 
study population into three MM groups, which included both 
physical and mental conditions, at baseline: no (zero to one 
condition), moderate (two to three conditions), and severe 
MM (four or more conditions).
Educational level
Data on educational level were collected from Statistics 
Denmark47,48 at the baseline of the study. Educational level 
was categorized according to United Nations Educational, 
Scientific and Cultural Organization’s International Stan-
dard Classification of Education.49 Based on information 
on the highest degree attained, the study population was 
divided into three groups according to years of schooling50: 
1) LEL: ≤10 years (e.g., no formal education, elementary 
school), 2) medium educational level (MEL): >10 and 
≤15 years (e.g., high school), and 3) HEL: >15 years 
(e.g., primary school teacher, journalist, physiotherapist, 
or physician).
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Outcome
Information on death
The primary outcome was all-cause mortality. Information 
on death was obtained from the Danish Civil Registration 
System,38 which holds continuously updated information on 
vital status. Information on death is updated on a daily basis. 
In a sensitivity analysis, we investigated premature mortality 
defined as death before the age of 75 years.
Covariates
Self-reported covariates
Self-reported baseline characteristics were obtained on the 
sub-cohort of respondents from the Danish National Health 
Survey (Figure 1). We included information on lifestyle 
factors in groupings: physical activity (light or no physical 
activity, moderate physical activity of ≥4 h/week, and hard 
physical activity of ≥4 h/week), alcohol habits (<7/<14, 
7–14/14–21, and >14/>21 units per week for females/males), 
smoking status (never, former, and current), body mass index 
(underweight, i.e., <18 kg; normal weight, i.e., 18–25 kg; 
overweight, i.e., 25–30 kg; or obese, i.e., >30 kg), ethnicity 
(Danish, other western background, or other), and self-rated 
physical and quality of life (measured by the Short-Form 
Health Survey (SF-12)51 by scores 0–100, with 100 being 
the best possible state of health).
Other covariates
From the Danish Civil Registration System,38 we obtained 
individual information on gender, date of birth, and civil 
status (cohabiting or single). The data were fully anonymized.
The study did not need approval from the regional ethics 
committee, but it was approved by the Danish Data Protection 
Agency (file number 2013–41-1719).
Statistical analysis
The demographic characteristics of both study cohort and 
respondent cohort according to educational level were evalu-
ated at baseline.
Hazard ratios (HRs) of all-cause mortality with 95% 
confidence intervals (95% CIs) were calculated using a 
Cox proportional hazards model with age as the timescale. 
We checked the proportional hazards assumption using log 
(−log[survival]) plots, and we saw no violations.
We developed four adjustment models. In the crude 
model (M1), we included the intrinsic correction for age 
used as timescale. In the second model (M2), we further 
adjusted for sex and cohabitation status. In the third model 
(M3), we additionally adjusted for all physical and mental 
conditions from the registers in the form of 39 dummy 
variables to account for the differences in influence on 
mortality caused by each condition. In a fourth model (M4), 
260,961 invited to participate
18,458 excluded due to death,
emigration before start of study,
birth before 1921, or lack of residence
in Denmark since January 1, 1995 
239,547 invited and eligible for inclusion with
available information on education (100%)
2,956 excluded due to missing information on
education
88,001 survey nonrespondents with
information on education (37%)
151,546 survey respondents with
information on education (63%)
242,503 invited and eligible for inclusion
Figure 1 Flowchart of participants.
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which was only applied to the respondent cohort, we further 
adjusted for self-reported lifestyle factors and quality of 
life (SF-12). In the last model, we imputed missing survey 
data on lifestyle and socioeconomic factors in a chained 
equations model. This is a method based on sequential 
multivariate regressions on missing parameters that allows 
us to impute multiple variables. We included all our analy-
sis parameters, outcome variable, and time variable in the 
imputation model. Ordinal logistic regression was used 
for categorical variables and predictive mean matching for 
the SF-12 variables. We estimated that 20 imputation sets 
would be sufficient according to guidelines, and the result-
ing estimates were combined using Rubin’s rules. Multiple 
imputation operates under the assumption that given the 
variables used in the imputation procedure, the missing data 
are missing at random, which means that the probability 
that a value is missing depends only on observed values 
and not on unobserved values.52,53
The association between educational level and mortality 
was examined by setting the highest educational level as 
reference and applying M1, M2, and M3. The association 
between MM and mortality was examined by setting “0–1 
condition” as reference and applying M1 and M2. We then 
examined the association between educational level and 
mortality across MM groups by using M1, M2, and M3, 
and additionally applying M4 for survey respondents. Effect 
modification was assessed by testing for multiplicative 
interaction using a likelihood ratio test. The point estimates 
and the corresponding 95% CIs were presented graphically; 
point estimates for educational level were adjusted using M3 
and calculated for each MM group, and the ratios between 
the MM groups were adjusted using M2 and scaled by risk-
time-weighted average HRs within each MM group using 
the non-MM group as the reference group. This scaling was 
done to reflect the actual observed differences in condition 
status between MM groups (Figure 2).
Using a standard Kaplan–Meier approach, we calculated 
the cumulative mortality proportion (CIP) for death after 
1year in all combinations of educational level across each 
MM group (CIP after 1 year [CIP]
1y
). To assess the magnitude 
of educational level across MM groups in absolute numbers, 
we multiplied the CIP
1y
 with the adjusted attributable fraction 
(HR-1)/HR and yielded the excess CIP
1y
.54
Multiple sensitivity analyses were performed. In one 
sensitivity analysis, we examined the effect of educational 
level on premature mortality across MM groups. In this 
analysis, individuals were censored at the time of their 75th 
birthday; once a person turned 75, he/she was no longer at 
risk of dying prematurely, that is, turning 75 years old is a 
competing risk of dying prematurely. As a consequence of 
this, the CIP
1y
 was estimated using a competing risk method 
in this sensitivity analysis.55,56 As in the main analysis, HRs 
were calculated using a standard Cox proportional hazards 
model with age as the timescale.
In another analysis, we excluded people <35 years at 
baseline to test the hypothesis on a cohort who more certainly 
had completed their education.
We also examined whether the effect of educational level 
across MM groups in the entire cohort differed by sex and 
age registered using stratified analyses. A likelihood ratio 
test was applied to test for multiplicative interaction across 
the different strata.
Respondent and nonrespondents were compared regard-
ing demographic characteristics and mortality. The effect 
of educational level across MM groups was examined and 
compared between respondents and nonrespondents by 
using M3.
All analyses were performed using Stata 13 (Stata Cor-
poration, College Station, TX, USA).
Results
We followed 239,547 individuals invited to participate 
in the Danish National Health Survey 2010 for a total of 
910,400 person-years at risk (mean follow-up time: 3.8 
years;  Figure 1). In the study cohort, 29% had LEL, 48% 
High
1
2
3
4
5
6
Medium
H
az
ar
d 
ra
tio
Educational level
0–1 conditions 2–3 conditions ≥4 conditions
Low
Figure 2 Association between educational level, multimorbidity group, and 
mortality hazard ratio.
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had MEL, and 23% had HEL at baseline. LEL was more 
common among participants, who were elderly and single, 
had ≥4 diseases, and had a psychiatric condition (Table 1).
The absolute number of long-term conditions increased 
with decreasing educational level (Figure 3).
Association between educational level 
and mortality across MM groups
We identified 12,480 deaths, of which 9,742 (78%) were among 
people with MM. Among people with LEL 6,607 people 
(9.5%) died, among people with MEL 4,601 (4.0%) died, and 
among people with HEL 1,272 (2.3%) died during follow-up.
The mortality increased with decreasing educational level 
and with increasing number of underlying diseases. The asso-
ciation between educational level and mortality measured on 
the relative scale (HRs) attenuated with increasing level of 
MM; the P-value for interaction was <0.001 (Table 2). The 
mortality rate was 126% higher among people with LEL 
compared with those with HEL in the group of people with 
0–1 conditions (HR: 2.26, 95% CI: 2.00–2.55), whereas the 
corresponding estimates were 14% higher among people with 
≥4 diseases (HR: 1.14, 95% CI: 1.04–1.24) after adjusting 
for age, sex, cohabitation status, and the 39 conditions (M3). 
However, the absolute number of deaths was higher among 
people with LEL than those with HEL in all MM groups; 
for those with 0–1 conditions, 335 persons (0.8%) with HEL 
died versus 1,293 (3.4%) persons with LEL. For those with 
≥4 diseases, 514 persons (18.3%) with HEL died (CIP
1y
: 
5.59%) versus 3,245 persons (25.9%) with LEL (CIP
1y
: 
7.27%; Figure 4).
Theoretically, had those with LEL had the same risk of 
dying as those with HEL, 0.40% of people with LEL would 
not have died in the group of people with 0–1 diseases and 
0.89% in the group of people with ≥4 diseases (Table 2).
Figure 2 shows that the background mortality was highest 
for people with severe MM and the association for education 
levels off with increasing morbidity.
Association between educational level 
and premature mortality across MM 
groups
We identified 5,170 premature deaths: 2,215 people (3.2%) 
with LEL died prematurely and 36% of them had ≥4 condi-
tions; 596 people (1.1%) with HEL died prematurely and 
30% of them had ≥4 conditions. In the group of people with 
≥4 conditions, the overall mortality was 14% higher for 
people LEL compared with people with HEL (HR: 1.14, 
95% CI: 1.04–1.24), whereas the corresponding estimates 
for premature mortality as outcome was 40% (HR: 1.40, 
95% CI: 1.17–1.67) after adjusting for age, sex, cohabitation 
status, and the 39 conditions (M3). The absolute number of 
premature deaths was higher among people with LEL than 
those with HEL in all MM groups: for those with ≥4 diseases, 
147 persons with HEL died (CIP
1y
: 2.99%) versus 803 per-
sons with LEL (CIP
1y
: 4.17%). Theoretically, if those with 
LEL had the same risk of dying as those with HEL, 0.24% 
Table 1 Baseline characteristics according to educational level (entire study population)
Baseline characteristics Participants (%)  
(n=239,547)
Educational level (%)
Low (£10 years)  
(n=69,491)
Middle (10–15 years) 
(n=115,597)
High (>15 years) 
(n=54,459)
Age at baseline (years)
25–34 28,044 (11.7) 4,317 (15.4) 14,732 (52.5) 8,995 (32.1)
35–44 46,222 (19.3) 8,009 (17.3) 24,904 (53.9) 13,309 (28.8)
45–54 50,411 (21) 12,110 (24) 26,144 (51.9) 12,157 (24.1)
55–64 51,277 (21.4) 14,456 (28.2) 25,485 (49.7) 11,336 (22.1)
65–74 38,162 (15.9) 15,886 (41.6) 16,324 (42.8) 5,952 (15.6)
75–89 25,431 (10.6) 14,713 (57.9) 8,008 (31.5) 2,710 (10.7)
Gender
Female 11,7217 (48.9) 30,862 (26.3) 63,490 (54.2) 22,865 (19.5)
Male 122,330 (51.1) 38,629 (31.6) 52,107 (42.6) 31,594 (25.8)
Cohabitation status
Living alone 72,223 (30.1) 27,762 (38.4) 30,877 (42.8) 13,584 (18.8)
Cohabiting 167,324 (69.9) 41,729 (24.9) 84,720 (50.6) 40,875 (24.4)
Conditions, number
0–1 165,643 (69.1) 37,743 (22.8) 84,326 (50.9) 43,574 (26.3)
2–3 49,085 (20.5) 19,199 (39.1) 21,813 (44.4) 8,073 (16.4)
≥4 24,819 (10.4) 12,549 (50.6) 9,458 (38.1) 2,812 (11.3)
Psychiatric condition
Yes 23,519 (9.8) 9,293 (39.5) 9,887 (42) 4,339 (18.4)
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of the people with LEL would not have died in the group 
of people with 0–1 conditions and 1.15% with LEL in the 
group of people with ≥4 diseases (Table 3). Among people 
with LEL, 2,214 (3.2%) died prematurely during follow-up 
and 36% of them had severe MM. Among people with HEL, 
596 (1.1%) died prematurely during follow-up and 25% of 
them had severe MM.
Subanalyses
Effect modification by age and sex
We found that the association between educational level and 
mortality across MM groups decreased slightly with increas-
ing age (Table S1). The association was similar for men and 
women (Table S2)
Number of long-term conditions
0
0 1 2 3 4
Low educational level
Medium educational level
High educational level
5 6 7 8 9+
20
40
60
80
100
P
er
ce
nt
ag
e
Figure 3 The distribution of educational level relative to the number of long-term 
conditions.
Table 2 Mortality HRs for educational level across multimorbidity groups (entire study population)
Multimorbidity 
group
Educational level Deaths CIP1y 
(%)
M1a M2b M3c
HR 95% CI HR 95% CI HR 95%CI Excess CIP1y (%)
d
0–1 conditions 
(n=165,643)
High (n=43,574) 335 0.14 1.00 Ref 1.00 Ref 1.00 Ref Ref
Medium (n=84,326) 1110 0.22 1.53 (1.36–1.73) 1.45 (1.28–1.64) 1.45 (1.28–1.64) 0.07
Low n=37,743) 1293 0.71 2.37 (2.10–2.68) 2.27 (2.01–2.56) 2.26 (2.00–2.55) 0.40
2–3 conditions 
(n=49,085)
High (n=8,073) 423 1.25 1.00 Ref 1.00 Ref 1.00 Ref Ref
Medium (n=21,813) 1486 1.63 1.25 (1.12–1.39) 1.21 (1.09–1.35) 1.20 (1.08–1.34) 0.27
Low (n=19,199) 2069 2.62 1.38 (1.24–1.53) 1.39 (1.25–1.54) 1.35 (1.22–1.50) 0.68
≥4 conditions 
(n=2,481)
High (n=2,812) 514 5.59 1.00 Ref 1.00 Ref 1.00 Ref Ref
Medium (n=9,458) 2005 6.15 1.20 (1.09–1.32) 1.15 (0.05–1.27) 1.12 (1.02–1.23) 0.66
Low (n=12,549) 3245 7.27 1.16 (1.06–1.28) 1.18 (1.08–1.30) 1.14 (1.04–1.26) 0.89
Notes: P-value <0.001 for no interaction between educational level and multimorbidity group for M3. aAdjusted for age. bLike M1 with further adjustment for gender and 
cohabitation status. cLike M2 with further adjustment for 39 register-based, selected conditions. dExcess deaths were calculated by multiplying the CIP1y by the adjusted 
attributable fraction (HR-1)/HR for M3.
Abbreviations: CIP1y, cumulative mortality proportion after 1 year; HR, hazard ratio; CI, confidence interval; Ref, reference.
≤10
0–1 conditions
2–3 conditions
≥4 conditions
11–15 ≥16 ≤10 11–15
Educational level (years)
≥16 ≤10 11–15 ≥16
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Figure 4 Cumulative incidence proportions of death at 1 year across educational levels and multimorbidity group.
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Lifestyle and quality of life in survey respondents
We performed a subgroup analysis of the survey respondent 
group with self-reported data on lifestyle and quality of life 
SF-12 (Figure 1; Table S3). We followed this cohort for a 
total of 580,646 person-years at risk (mean follow-up time: 
3.8 years) and identified 5,875 deaths of which 4,573 (78%) 
occurred in people with MM and 2,789 (47%) occurred in 
people with LEL.
The association between educational level and mortal-
ity disappeared for people with MM when we adjusted for 
lifestyle factors and SF-12 (Table S4).
Comparison of respondent and nonrespondent 
cohorts
The response rate in the survey was 63%. Nonrespondents 
were more likely to be male, single, aged 25–45 years or 
≥75 years, to have multiple diseases, lower educational level 
(Table S5), and higher mortality than respondents (Table S6). 
However, the association between educational level and 
mortality was remarkably similar for respondents and non-
respondents in most strata of MM (Table S7).
The results were consistent with our main findings when 
we excluded participants under the age of 35 years (data not 
shown).
Discussion
In this population-based cohort study, we confirmed that both 
LEL and MM were associated with higher overall mortal-
ity.19,57 Further, our findings suggested that the relative risk 
of overall and premature mortality for people with LEL 
compared with HEL decreased with increasing number of 
underlying chronic conditions.
However, the absolute number of both overall and prema-
ture deaths was higher among people with LEL than those 
with HEL in all MM groups and the highest proportion of 
deaths that theoretically could have been avoided, given 
people with LEL had the same mortality as those with HEL, 
was found in the group of people with ≥4 diseases: both for 
overall and premature mortality. Among people with LEL, 
36% of those who died prematurely had severe MM, indi-
cating that the association between LEL and higher overall 
and premature mortality could be driven by MM. In other 
words, the findings indicate that the relative effect on death 
decreases the more diseases you suffer from, because the 
diseases have a direct effect on mortality as seen from the 
absolute numbers.
Adjusting for lifestyle factors and quality of life (SF-12) 
eliminated the statistical association between educational 
level and mortality in people with MM.
Strength and limitations
We followed a large and representative sample of the Dan-
ish population37 for up to 4 years with virtually no loss to 
follow-up. The survey response rate was 63%. Even though 
the respondent group differed from the nonrespondent group 
on a range of baseline characteristics, the association between 
educational level, MM, and mortality was still remarkably 
similar in the two groups. This finding speaks against selec-
tion problems.
The use of national registers with prospectively recorded 
data ensured highly valid and complete data on deaths, edu-
cational level, and baseline socioeconomic factors.58 The 
MM groups were established by an algorithm combining 
information from Danish national registries with secondary 
Table 3 Premature mortality HRs for educational level across multimorbidity groups (full study population)
Multimorbidity 
group
Educational level Deaths CIP1y 
(%)
M1a M2b M3C
HR 95% CI HR 95% CI HR 95% CI Excess CIP1y (%)
d
0–1 conditions 
(n=159,826)
High (n=42,861) 249 0.12 1.00 Ref 1.00 Ref 1.00 Ref Ref
Medium (n=82,459) 805 0.18 1.55 (1.35–1.79) 1.45 (1.26–1.67) 1.45 (1.26–1.67) 0.06
Low (n=34,506) 704 0.43 2.53 (2.19–2.93) 2.31 (2.00–2.67) 2.31 (1.99–2.67) 0.24
2–3 conditions 
(n=39,603)
High (n=7,045) 200 0.75 1.00 Ref 1.00 Ref 1.00 Ref Ref
Medium (n=18,796) 788 1.18 1.45 (1.24–1.70) 1.40 (1.20–1.63) 1.43 (1.22–1.67) 0.35
Low (n=13,762) 708 1.50 1.67 (1.42–1.95) 1.60 (1.37–1.88) 1.57 (1.34–1.84) 0.54
≥4 conditions 
(n=14,684)
High (1,843) 147 2.99 1.00 Ref 1.00 Ref 1.00 Ref Ref
Medium (6,334) 766 4.06 1.54 (1.29–1.83) 1.45 (1.21–1.73) 1.34 (1.12–1.60) 1.03
Low (6,510) 803 4.17 1.56 (1.31–1.86) 1.52 (1.28–1.82) 1.40 (1.17–1.67) 1.19
Notes: P-value <0.001 for no interaction between educational level and multimorbidity group for M3. aAdjusted for age. bLike M1 with further adjustment for sex and 
cohabitation status. cLike M2 with further adjustment for and 39 register-based, selected conditions. dExcess deaths were calculated by multiplying the CIP1y by the adjusted 
attributable fraction (HR-1)/HR for M3.
Abbreviations: CIP1y, cumulative mortality proportion after 1 year; HR, hazard ratio; CI, confidence interval; Ref, reference. 
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care diagnosis and drug prescriptions on an individual level. 
The algorithm has been described in detail in a previous study 
of a similar cohort.39 We obtained information on educational 
level at baseline for 98.8% of the participants. People with 
missing data on educational level were equally distributed 
across gender, age, and MM groups, and we have no reason 
to believe that the association between educational level 
and mortality was biased by this approach to missing data. 
In a subgroup analysis of survey respondents, we further 
controlled for lifestyle factors and self-rated health. Adverse 
lifestyle is a well-known prognostic factor for MM and SF-12 
can be seen as a proxy for disease severity. The sample size of 
the study cohort allowed us to investigate mortality at several 
levels of education and MM and to adjust for many potential 
confounders. The differences in group sizes reflect the target 
population, and both our relative and absolute statistical 
estimates take this into account. Owing to our large study 
sample, there was sufficient number of events to estimate the 
effect with each group.
An established definition of SES does not exist in the lit-
erature. Krieger et al have described socioeconomic position 
as referring to the social and economic factors that influence 
the type of positions that individuals or groups may hold 
within the structure of a society.59 Galobardes et al state that 
there is no single best indicator of SES that is both suitable 
for all study aims and yet applicable at all time points in all 
settings.60 In our study, we chose years of schooling as the 
measure of SES and categorized people into three groups. 
Education as a proxy for SES is historically founded in 
Weber’s theory of a status domain.61 Educational level cap-
tures both the transition from parents’ SES to own adulthood 
SES and serves as a determinant for future employment and 
income.62 Additionally, educational level may express a per-
son’s ability to navigate in the health care system; it is fixed 
early in adult life and reported consistently.54
Compared to income as a marker of SES, educational 
level is less volatile, less affected by changes in health status 
that could impair work capacity, and more stable regarding 
different use of public benefits such as state educational 
grants and postemployment benefits.
One important limitation in our study was that the under-
standing of educational level varies among birth cohorts 
because considerable changes in educational opportunities 
have been seen over the recent decades. Hence, a majority 
of the low educated was found in the older birth cohorts. 
We addressed this challenge by choosing age as the time-
scale and letting all individuals enter the study at the same 
date. Additionally, we performed a stratified analysis after 
dividing the study population into two age groups of equal 
size. Another limitation was that we obtained no information 
about type of education when using years of schooling as SES 
measure. Furthermore, educational level does not measure 
human or social capital. The relationship between health and 
education is complex because formal education is a dynamic 
process that provides people with multiple resources. Data 
on educational level from Statistics Denmark were collected 
prospectively and are regarded as valid.47
In the literature, no standard method of measuring MM 
exists. Consensus is lacking on which conditions to include, 
how to define the conditions, and whether or not to weight the 
measure.40 The MM status in our study was based on clini-
cally acknowledged conditions from all Danish hospitals and 
outpatient clinics, including recommended key diseases.63 
In order to capture common diseases treated in primary 
care, our algorithm also included redeemed drug prescrip-
tions from all Danish pharmacies. This approach was taken 
because primary care diagnoses were not available. Several 
studies on MM use simple disease count models to describe 
the MM burden.41 We weigh the diseases by adjusting for 
each disease as a dummy variable within each MM stratum; 
this allows the MM groups to have a different impact on the 
education level categories due to different combinations of 
the diseases within each educational level. By doing this, 
we reduce the residual confounding that may emerge from 
associating LEL with more severe disease. Yet, we could not 
account for untreated primary care conditions and the dura-
tion or severity of each condition. If people with LEL have 
an earlier onset of some diseases and more severe states of 
individual diseases, confounding of the results may occur. 
We considered people with no chronic diseases and people 
with one chronic disease as one group. When stratifying on 
no and one chronic disease, the estimates were not clinically 
significantly different from each other (data not shown).
In our study, we were able to control for a wide range of 
potential confounders at the individual level. We were able 
to adjust for lifestyle factors and quality of life in the survey 
respondent cohort. We were not able to include information 
on nutrition that could be a confounder for the association. 
However, we have adjusted for BMI and other lifestyle fac-
tors associated with nutrition. Consequently, the association 
between educational level and mortality disappeared; this 
indicates that confounding from these factors may play a 
role. However, we cannot rule out that some of the factors 
that we adjusted for are intermediate variables; LEL may lead 
to an unhealthy lifestyle, which again could lead to higher 
mortality. If so, adjustment for lifestyle factors could result in 
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underestimation of the true association between educational 
level and mortality.54 Even though our study includes many 
potential confounders, we acknowledge that observational 
studies may be subject to residual confounding. However, 
from this finding, it can be discussed how resources should 
be used. Maybe it would be more reasonable to focus on 
people having an adverse lifestyle who are at greater risk of 
developing MM than those who are already multimorbid in 
order to influence mortality.
Comparison with other studies
In line with the findings from cross-sectional studies in other 
countries, we found that MM was associated with LEL.64 Our 
study suggests that the impact of this social determinant on 
prognosis diminished for people diagnosed with multiple 
chronic conditions. This finding is consistent with a newly 
published study from Ontario, Canada,65 in which the effect 
of increasing chronic condition burden on mortality was 
shown to be similar across neighborhood income quintiles 
among older people. However, in our study, we were able to 
look at SES at the individual level across all age groups for 
39 long-term conditions. In another study from the UK, the 
researchers found that the relative socioeconomic inequali-
ties in mortality were smaller at higher levels of morbidity.66  
They used deprivation categories and included only four 
chronic diseases. Many studies have investigated the indi-
vidual impact of educational level and MM on mortality. Yet, 
as far as we know, our study is the first to contribute with 
knowledge about the impact of individual educational level 
on mortality for people with and without MM in a setting 
with universal health care.
The Danish health care system is predominantly financed 
through income tax, and universal care is available to all 
Danish residents. The associations found in our study could 
possibly be stronger in countries without universal health 
care or free education.
Conclusion and implications
Our study suggests that educational level is an important 
prognostic factor for all-cause mortality and premature 
mortality. The findings also indicate that this association is 
modified by level of MM and confounded or modified by 
lifestyle factors and quality of life. However, the increase 
in absolute number of deaths for people with LEL com-
pared with people with HEL was greatest in the group of 
people with severe MM. These findings suggest that both 
educational level and lifestyle factors must be taken into 
account when treating people with MM in order to reduce 
the socioeconomic inequalities in mortality. Increased focus 
should be directed toward preventing early development of 
long-term conditions, especially in people with low SES.
Disclosure
The authors report no conflicts of interest in this work.
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